SKVI (Skinvisible) LT-Debt-to-Total-Asset : 36.05 (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Skinvisible LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Skinvisible's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 36.05.

Skinvisible's long-term debt to total assets ratio increased from Sep. 2023 (30.60) to Sep. 2024 (36.05). It may suggest that Skinvisible is progressively becoming more dependent on debt to grow their business.

Skinvisible LT-Debt-to-Total-Asset Historical Data

The historical data trend for Skinvisible's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skinvisible LT-Debt-to-Total-Asset Chart

Skinvisible Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

6.99

9.68

11.37

13.13

34.81

Skinvisible Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															30.60	34.81	35.11	35.10	36.05

Skinvisible LT-Debt-to-Total-Asset Calculation

Skinvisible's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	5.674	/	0.163
	=	34.81

Skinvisible's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	5.372	/	0.149
	=	36.05

Skinvisible (OTCPK:SKVI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Skinvisible LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Skinvisible's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Skinvisible Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Skinvisible Inc (OTCPK:SKVI) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

6320 South Sandhill Road, Suite 10, Las Vegas, NV, USA, 89120

Website

https://www.skinvisible.com

Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. The Company is also exploring new opportunities in large medical markets outside of the dermatology market such as obesity and other potential markets where a topical or transdermal solution would be a viable alternative.

Executives

St James David M	director	3395 S. JONES BLVD., #169, LAS VEGAS NV 89146
Doreen Mcmorran	10 percent owner	6320 S. SANDHILL RD UNIT 10, LAS VEGAS NV 89120
Brian Piwek	director	9014 GLENEAGLE DRIVE, BLAINE WA 98230
E Greg Mccartney	director	#307-15338 18TH AVENUE, SURREY BC A1 V4A 1W8
Jost Steinbruchel	director	7, RUE DES BATTOIRS, POBOX #214, 1211 GENEVA 4 V8 000000
Robert F Lutz	director, 10 percent owner
Terry Howlett	director, 10 percent owner, officer: President & Chief Exec.Officer	6320 S. SANDHILL ROAD, SUITE #10, LAS VEGAS NV 89120
Skinvisible Inc	director, 10 percent owner, officer: President	6320 S SANDHILL ROAD, SUITE 10, LAS VEGAS NV 89120
Lutz Family Trust	10 percent owner	8322 WEST TONTO LANE, PEORIA AZ 85382